Pharma stocks underperform in 2026 due to pricing reforms

Market overview

Major pharmaceutical companies like Pfizer, Merck, and Eli Lilly would face margin pressure from drug price controls. Analysts expect these stocks to decline by at least 10% relative to the S&P 500 in 2026.

price prediction market

Implied probability (Yes)

68%

Source: user-generated

More price markets

• Bitcoin price exceeds $150,000 by end of 2026 — 68% Yes
• Bitcoin price recovers to $50,000 by December 2026 — 62% Yes
• Bitcoin price exceeds $100,000 within 6 months of Clarity Act passage — 70% Yes
• Coinbase stock to rise 15% by June 2026 amid crypto regulation clarity — 72% Yes
• NY crypto tax revenue will exceed $200M in 2027 — 65% Yes
• Will stock drop >15% on next financing terms? — 45% Yes
• Will enGene raise additional equity financing before Q1 2027? — 80% Yes
• Trading volume on Kalshi’s crypto futures exceeds $500M in first month — 60% Yes

Browse all price markets →